Quantcast
Channel: News-Medical.Net onsolis News Feed
Viewing all articles
Browse latest Browse all 26

Enrollment complete in BDSI's pivotal pharmacokinetic study of BNX for opioid dependence

$
0
0
BioDelivery Sciences International, Inc. announced that enrollment and the clinical portion of the pivotal pharmacokinetic study for BEMA Buprenorphine/Naloxone (BNX) for the treatment of opioid dependence has been completed.

Viewing all articles
Browse latest Browse all 26

Trending Articles